Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
about
Compounds from Cynomorium songaricum with Estrogenic and Androgenic Activities Suppress the Oestrogen/Androgen-Induced BPH ProcessRole of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis.Anti-proliferative activities of finasteride in benign prostate epithelial cells require stromal fibroblasts and c-Jun geneLPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia.Reduction in breast cancer susceptibility due to XbaI gene polymorphism of alpha estrogen receptor gene in JordaniansEndocrine control of benign prostatic hyperplasia.Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.The role of the endothelin axis in promoting epithelial to mesenchymal transition and lymph node metastasis in prostate adenocarcinoma.Melatonin inhibits 17β-estradiol-induced migration, invasion and epithelial-mesenchymal transition in normal and endometriotic endometrial epithelial cells.MicroRNA-340 Inhibits Epithelial-Mesenchymal Transition by Impairing ROCK-1-Dependent Wnt/β-Catenin Signaling Pathway in Epithelial Cells from Human Benign Prostatic Hyperplasia
P2860
Q33735698-87A05A32-6056-47EB-822E-A19B4AB2A57CQ35872623-817040E7-37F0-4B0A-933C-E673926199E3Q36280003-8AA6C8BD-ADCA-4846-BE70-9FE2F156D80CQ36950638-3D299970-7FBC-4285-BC3B-D3733BA8527DQ37613504-E43E8118-201C-455E-90CE-0082F0548F80Q38811041-10BE36D2-FC5A-4059-B4DE-7489AC2E1A90Q42321749-BFBC6974-1C54-4D28-B2B0-5639DA4746FBQ42514114-07845B6B-E008-4030-B5E0-E03B7E48E9C4Q45454130-5C860227-2BB9-4F90-A28C-233B69C2496FQ55427770-7EE744B9-1C38-4C88-90BE-594AC0634291Q58765820-9AADFEB0-BCB8-4994-BB45-B827A0EA16D7
P2860
Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Epithelial-to-mesenchymal tran ...... benign prostatic hyperplasia.
@en
Epithelial-to-mesenchymal tran ...... benign prostatic hyperplasia.
@nl
type
label
Epithelial-to-mesenchymal tran ...... benign prostatic hyperplasia.
@en
Epithelial-to-mesenchymal tran ...... benign prostatic hyperplasia.
@nl
prefLabel
Epithelial-to-mesenchymal tran ...... benign prostatic hyperplasia.
@en
Epithelial-to-mesenchymal tran ...... benign prostatic hyperplasia.
@nl
P2093
P2860
P356
P1433
P1476
Epithelial-to-mesenchymal tran ...... benign prostatic hyperplasia.
@en
P2093
Haitao Liu
Helmut Klocker
Jiandang Shi
Xiaoling Du
Xiaoyu Shi
P2860
P304
P356
10.1002/PROS.22814
P577
2014-04-22T00:00:00Z